The synergistic effect of combining a GHRH analog with a growth hormone secretagogue creates stronger GH pulses than either peptide achieves independently
Beyond Month 6: Maintenance Most patients continue at 2.4 milligrams weekly through month 12, when full clinical trial endpoints are typically reached
Clinical trial participants who took Zepbound lost an average of 50 pounds over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds
References 1 AbudureyimuM.YuW.CaoR
Appl Microbiol Biotechnol 66:233242
Research has examined its effects on body weight, food intake, gastric emptying rate, postprandial glucose excursions, and metabolic rate in relevant animal models